Clinical Evaluation of Two Approved Contact Lenses

Completed · Not applicable

Conditions studied: Visual Acuity

In brief

Adaptive, randomized, subject-masked, dispensing study to evaluate the short-term, clinical performance of two FDA-approved contact lens.

Key facts

Study ID

NCT02759692

Run by

Johnson & Johnson Vision Care, Inc.

People needed

283

Starts

2016-04-01

Expected to finish

2016-06-01

Last updated by the study team

2017-08-18

Who can join

Age: 18 and older, up to 39. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
• The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
• The subject must be between (and including) 18 and 39 years of age.
• The subject must be an adapted wearer of spherical soft contact lenses in both eyes. That is, the subject must wear their habitual lenses at least five (5) days per week and eight (8) hours per day, worn for at least 30 days immediately preceding the study.
• Have vertex-corrected distance refraction that allows a plano over-refraction with the available contact lens powers of -1.00 to -6.00 Diopters (D) in each eye.
• Have refractive astigmatism, if present, of less than or equal to 1.00 D in each eye.
• The subject must have best corrected visual acuity of 20/25 or better in each eye.

You may not qualify if…

• Currently pregnant or breastfeeding (subjects who become pregnant during the study will be discontinued).
• Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
• Any autoimmune disease or use of medication, which may interfere with contact lens wear.
• Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, or aphakia.
• Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.).
• Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.
• Any ocular infection.
• Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• Monovision, multi-focal, toric, or extended wear contact lens correction.
• Participation in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.
• History of binocular vision abnormality or strabismus that is likely to affect successful contact lens wear.
• Any infectious disease (e.g., hepatitis, tuberculosis) or contagious immunosuppressive diseases (e.g., HIV) by self-report.

Where it is running

• Becky Bizzle, OD — Montgomery, Alabama, United States
• Complete Family Eye Care of Fruit Cove — Jacksonville, Florida, United States
• Golden Family Eyecare — Sarasota, Florida, United States
• St. Lucy's Vision Center — Tampa, Florida, United States
• Eye Associates of Winter Park — Winter Park, Florida, United States
• VisualEyes, Inc. — Roswell, Georgia, United States
• Advantage Eyecare Associates, LLC — Neodesha, Kansas, United States
• Sacco Eye Group — Vestal, New York, United States
• Advanced Family Eye Care — Denver, North Carolina, United States
• Total Eye Care PA — Memphis, Tennessee, United States
• Brian Frazier, OD — Jacksonville, Texas, United States
• Timothy R. Poling, OD — Salem, Virginia, United States
• Ziegler Leffingwell Eyecare — West Allis, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.